StockData

InspireMD vs WORK Medical Technology

NSPR and WOK side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How NSPR and WOK compare

InspireMD grew revenue faster over the last twelve months (53.4% versus −14.4% for WORK Medical Technology).

WORK Medical Technology keeps more of each dollar of sales as profit, with a net margin of −10.9% compared with −484% at InspireMD.

InspireMD scores higher on the StockData Score (10 against 5 for WORK Medical Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricNSPRWOK
Size and price
Market cap$29.9M–
Share price$0.644$1.20
Change, 1 year−64.0%−100.0%
Change, 5 years−82.7%–
Beta (5Y)0.461.16
Employees12746
StockData Score
Total score10 (better)5
Valuation score3 (better)0
Growth score2 (better)0
Performance score02 (better)
Health score5 (better)3
Dividend score00
Valuation
P/S2.8×–
P/B1.0×–
FCF yield−142%–
Fair value$1.41–
Margin of safety54.4%–
Growth
Revenue growth (TTM)53.4% (better)−14.4%
Revenue growth, 5Y average29.3%–
Profitability
Gross margin18.1%23.8% (better)
Operating margin−494%–
Net margin−484%−10.9% (better)
FCF margin−392%49.9% (better)
Return on equity−203%−5.0% (better)
Return on invested capital−4320%–
Financial health
Debt / equity0.000.22 (better)
Net debt / EBITDA–9.70
Current ratio3.80 (better)1.37
Altman Z-score−11.98–
Piotroski F-score55
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions53.6%0.00%
Held by insiders31.6%0.22%
Insider net buying, 12 months$369K (better)−$178K
Short interest, % of float0.79%0.13%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.